Poland· PL-100060329
Scorbolamid
A salicylamid, kombinationen, exkl. psycholeptika product containing acidum ascorbicum + rutosidum + salicylamidum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Salicylamid, kombinationen, exkl. psycholeptika is registered in 2 of 19 countries.
Countries holding a registration under ATC N02BA55 (salicylamid, kombinationen, exkl. psycholeptika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Salicylamid, kombinationen, exkl. psycholeptika · ATC N02BA55
2 / 19 countries
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum ascorbicum + Rutosidum + Salicylamidum
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- N02BA55
- ATC class
- Salicylamid, Kombinationen, exkl. Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990034017
- gtin05909990991099
- gtin05909990991105
- gtin05909991225100
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N02BA55
Salicylamid, kombinationen, exkl. psycholeptika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0e7b6dc-e203-4816-92d0-c1c75c89cf3f GET /v1/drugs/e0e7b6dc-e203-4816-92d0-c1c75c89cf3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki drażowane",
"source": "urpl",
"strength": "100 mg + 5 mg + 300 mg",
"packaging": "05909990034017 ¦ OTC ¦ 8995\n20 tabl.\n05909990991099 ¦ OTC ¦ 77803\n6 tabl.\n05909990991105 ¦ OTC ¦ 77804\n10 tabl.\n05909991225100 ¦ OTC ¦ 108762\n40 tabl.",
"substance": "Acidum ascorbicum 100 mg + Rutosidum trihydricum 5 mg + Salicylamidum 300 mg",
"common_name": "Acidum ascorbicum + Rutosidum + Salicylamidum",
"pl_product_id": "100060329",
"pozwolenie_nr": "00340",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about salicylamid, kombinationen, exkl. psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.